Study Stopped
Funding issues
Somatosensory Evoked Potentials From the Lower Urinary Tract
1 other identifier
observational
N/A
1 country
1
Brief Summary
Spinal cord injury and other systemic neurological diseases (Multiple Sclerosis, Parkinson's disease) affect the integrity of lower urinary tract (LUT) function, leading to neurogenic lower urinary tract dysfunction (NLUTD). The urodynamic investigation is the current "gold-standard" for evaluating LUT function. Nevertheless, the sensory situation of the LUT cannot be investigated objectively. Furthermore, the current classification of the severity of the NLUTD due to spinal cord injury (SCI) does not represent the sensory situation of the LUT. Additional investigations therefore need to be established for assessing the sensory situation of the LUT. Somatosensory evoked potentials (SEPs) are an established method for investigating the processing of sensory nervous activity. However, SEPs from the LUT of SCI individuals have not yet been investigated. A novel technique, i.e. diffusion tensor imaging (DTI), allows to process magnetic resonance images (MRI) in order to visualize nerve fibers. Using DTI, the innervation of the bladder after SCI can be visualized. The structural presentation of bladder innervation will be compared with the functional results, i.e. the SEP of the LUT in SCI individuals. The primary objective of the proposed study is to elicit and characterize (latency, amplitude) the somatosensory evoked potentials (SEPs) from the bladder in individuals suffering from neurogenic lower urinary tract dysfunction as a result of spinal cord injury. Furthermore, the SEPs from the bladder will be compared with the SEPs from peripheral nerves (N. tibialis, N. pudendus, N. medianus). Moreover, the latency and amplitude of the SEPs from the bladder of individuals with somato-sensory complete spinal cord injury will be compared with those from the bladder of individuals with somato-sensory incomplete spinal cord injury. Finally, the structural innervation of the bladder after SCI will be compared with the remaining sensory function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2015
CompletedFirst Posted
Study publicly available on registry
May 20, 2015
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
July 31, 2025
July 1, 2025
2.4 years
May 15, 2015
July 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
occurrence of somatosensory evoked potentials from the bladder
within 1 week after enrollment into study
Secondary Outcomes (5)
latency of somatosensory evoked potentials
within 1 week after enrollment into study
peak-to-peak amplitude of somatosensory evoked potentials
within 1 week after enrollment into study
nerve fiber density around bladder
within 1 week after enrollment into study
fractional anisotropy of nerve fibers around bladder
within 1 week after enrollment into study
apparent diffusion coefficient of nerve fibers around bladder
within 1 week after enrollment into study
Other Outcomes (3)
age
1st day
gender
1st day
severity of spinal cord injury
1st day
Study Arms (2)
complete
individuals with somato-sensory complete spinal cord injury
incomplete
individuals with somato-sensory incomplete spinal cord injury
Eligibility Criteria
individuals with neurogenic lower urinary tract dysfunction as a result of spinal cord injury
You may qualify if:
- Informed Consent as documented by signature
- Chronic SCI of a minimum of 1 year
- Aetiology of SCI: traumatic
You may not qualify if:
- Age \< 18 years or \> 70 years
- Aetiology of SCI: non-traumatic
- History of bleeding disorder
- History of chronic neuropathic pain
- Intravesical botulinum toxin injections \< 12 months ago
- Bladder management using indwelling catheters (suprapubic, transurethral)
- Bladder augmentation
- Sacral deafferentation
- Sacral neuromodulation
- Acute, symptomatic urinary tract infection
- Pregnancy
- Urolithiasis
- Bladder cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Swiss Paraplegic Centre
Nottwil, Canton of Lucerne, CH-6207, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Jens Wöllner
Swiss Paraplegic Centre
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2015
First Posted
May 20, 2015
Study Start
January 1, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
July 31, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share